Find your next paid study

Madrigal Pharmaceuticals, Inc.NCT07848191

~$25 – $1,400

Actual pay is set by the research site.

Impact of Prescribed Physical Training on Systemic and Organ Specific Prognostic Markers in Prostate Cancer

This research is being done to assess the impact of a supervised and structured strength and conditioning program on cardiac remodeling in participants with pr…

Prostate Cancer

Massachusetts General HospitalNCT07768917

Actual pay is set by the research site.

Systemic Lupus Erthematosus (SLE)

Effect of Anti-inflammatory Diet in Systemic Lupus Erythematous

To study the effect of anti-inflammatory diet on clinical and biological outcomes in lupus

University of California, San DiegoNCT07713940

Actual pay is set by the research site.

Psychological StressSleep DisturbanceAnxiety Symptoms+2 more

Effects of Neuralli Mood Probiotic Supplementation on Stress, Sleep Disturbance, Mood, and Burnout: A 90-Day Single-Arm Study

This decentralized, single-arm study evaluates the effects of 90 days of daily Neuralli Mood supplementation on perceived stress, sleep disturbance, mood, anxi…

~$10 – $1,050

Actual pay is set by the research site.

Efforia, IncNCT07717385

Use of Total-Body PET to Quantify Systemic and Cutaneous Inflammation in Psoriasis Patients Before and After Intervention With a Nutritionally Balanced Diet

Psoriasis is a chronic inflammatory disease that affects the skin and joints in 2-3 % of people in the United States. This inflammation of the skin, joints, an…

Psoriasis

University of California, DavisNCT06574178

Actual pay is set by the research site.

Phase 2

SJALL23H: Combination Antigen-Directed Induction Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma

This is a Phase II clinical trial testing the use of two antigen-directed therapies, inotuzumab and blinatumomab, as part of induction therapy for children and…

Acute Lymphoblastic LeukemiaLymphoblastic Lymphoma

St. Jude Children's Research HospitalNCT06533748

~$75 – $2,000

Actual pay is set by the research site.

Phase 1

A First-in-Human Phase 1b, Single-Blind, Placebo-controlled Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD) Study to Evaluate Safety and Pharmacokinetics of GS-0415 in People With HIV-1 Who Are Virologically Suppressed on Antiretroviral Treatment

The goals of this clinical study are to learn more about the study drug GS-0415, safety, tolerability, and pharmacokinetics (PK) of single ascending doses (SAD…

HIV -1 Infection

Gilead SciencesNCT07719491

~$150 – $4,500

Actual pay is set by the research site.

Phase 3

A Phase III, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Once-Daily Oral ASC30 in Adult Participants With Obesity or Overweight With Type 2 Diabetes Mellitus (AURORA-2)

Study ASC30-302 (AURORA-2) is a Phase III, global, multicenter, randomized, double-blind, placebo-controlled study to investigate the long-term efficacy, safet…

ObesityOverweightChronic Weight Management+1 more

Ascletis Pharma (China) Co., LimitedNCT07743450

~$50 – $2,100

Actual pay is set by the research site.

Phase 2

A Phase 2b, Open-label, Multicenter, Randomized Parallel-Group, Two-Stage, Study of an Immunotherapeutic Treatment DPX-Survivac and Pembrolizumab, With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (VITALIZE)

This is a Phase 2b, randomized, open label study to assess the safety and efficacy of DPX-Survivac and pembrolizumab, with and without low-dose cyclophosphamid…

Relapsed Diffuse Large B-cell LymphomaRefractory Diffuse Large B-cell Lymphoma

ImmunoVaccine Technologies, Inc. (IMV Inc.)NCT04920617

~$75 – $2,800

Actual pay is set by the research site.

Phase 1

A Phase 1, Open-label, Single-dose, Parallel-group Study Evaluating the Pharmacokinetics of Oral Repinatrabit (JNT-517) Immediate Release Tablet in Hepatic or Renal Impaired Adult Participants Matched to Adult Participants With Normal Hepatic and Renal Function

This trial is intended to understand how the body processes repinatrabit in people with moderate liver impairment and severe kidney impairment and also to comp…

Phenylketonuria

Otsuka Pharmaceutical Development & Commercialization, Inc.NCT07713758

~$500 – $10,500

Actual pay is set by the research site.

Phase 4

Incidence of Pain During Reanesthetization in Mohs Micrographic Surgery Using Lidocaine, Bupivacaine, Chlorprocaine or Mepivacaine: A Multicenter, Randomized Controlled Trial

To compare several local anesthetics when used during dermatological surgery.

Mohs Micrographic SurgeryAnesthesia, Local

Baylor Research InstituteNCT07601750

~$25 – $1,500

Actual pay is set by the research site.

ALL, ChildhoodBehavior, Health

A Healthy Weight Intervention for Family Stress During the Early Phases of ALL Treatment: NOURISH-ALL

The purpose of this study is to conduct a single arm pilot of the NOURISH-ALL (Nourishing Our Understanding of Role modeling to Improve Support and Health in A…